Escherichia coli is a bacterium that can affect our health or even kill. Like most bacteria, E. coli is able to change and progress into different forms based on genetic changes that they can go through. One example of this genetic change is shown in the E. coli becoming immune to ampicillin is blood infections. Because ampicillin has been used so frequently to fight the symptoms of an E. coli infection, the bacteria has been able to change itself genetically by producing more of an inhibitor resistant TEM in order to continue it’s genetic line and reproduce causing infections in humans (Walters-Toews, et al. 2011). Another example from the science field would be an experiment that suggests that E. coli is not only becoming resistant to ampicillin, but also other antibiotics including Cotrimoxazole and Cefuroxime (Renal & Urology News, 2007). This experiment is meant to prove that through genetic transfer using plasmid DNA, the E. coli can become bioluminescent and immune to the ampicillin. By adding plasmid DNA to the E. coli cells, the genetic composition of the cells will be different. I predict that the E. coli cells containing no ampicillin will be able to grow colonies. I also predict that the plates with plasmid DNA will show signs of bioluminescence. The plate with ampicillin present with no plasmid DNA will not be able to grow colonies and will not be capable of bioluminescence. Methods:
The following experiment method is based on the procedure given through the Biology Department at UWM (Wimpee, 2006). This experiments started with two tubes of 100 uL E. coli cells, labeled one and two. Tube one just contained normal E. coli cells. Tube two was the tube with the plasmid added to it. The first step in this experiment was to add plasmid DNA, the “mini chromosomes” of the bacteria, to the E. coli cells in order to change the genetic makeup of them. I then added 10 uL of the plasmid to tube two. The next step was to chill both the tubes...
Cited: Empiric uti therapy switch suggested: Study finds low rates of e. coli susceptibility to ampicillin, cotrimoxazole, and cefuroxime. (2007). Renal & Urology News, Nov, 2007, Vol.6(11), P.23(1), 6(11), 23.
Waltner-Toews, R., et al. (2011). Clinical characteristics of bloodstream infections due to ampicillin-sulbactam-resistant, non-extended- spectrum-beta-lactamase-producing escherichia coli and the role of tem-1 hyperproduction. Antimicrobial Agents and Chemotherapy, Feb, 2011, Vol.55(2), P.495-501, 55(2), 495-501.
Wimpee, C. 2006. BIO SCI 152 Laboratory 2: Gene Transfer in E. coli. Ed. S. Hoot. Available
Please join StudyMode to read the full document